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ABSTRACT 
Dyslipidaemia (Medovikara) is a major health problem in both developed and developing nations. 
It leads to Atherosclerosis, which is a major factor in the development of Cardiovascular diseases. 
Modern medications available to Dyslipidaemia are potentially hazardous. Cirabilwa (Holoptelea 
integrifolia Planch.) is a large deciduous tree distributed throughout the greater part of India upto 
an altitude of 2000 ft. It is used in the treatment of various diseases including Dyspepsia, 
Flatulence, Colic, Helminthiasis, Vomiting, Skin diseases, Diabetes Mellitus, Haemorrhoids and 
Rheumatism. It is included in many Medohara ganas (groups of drugs having anti dyslipidaemic 
action) like Lekhana mahakashaya group (group of drugs that dessicate and scrape away the 
morbid tissues especially Meda and Kapha) of Caraka Samhita; Shleshma samsamana (groups of 
drugs which decrease Kapha), several Kaphamedohara groups (groups of drugs which decrease 
Meda and Kapha) like Saalasaradi, Varanadi, Aragwadadi, Asanadi and Arkadi of Susruta Samhita; 
Asanadi, Varanadi, Aragwadadi and Arkadi groups of Ashtanga Hridaya. This is an attempt made to 
explain the Medohara action of Cirabilwa according to Ayurvedic as well as modern aspect.  
KEYWORDS: Cirabilwa, Medohara, Dyslipidaemia, antidyslipidaemic, Holoptelea integrifolia. 
INTRODUCTION
Non communicable diseases (NCDs) are the 
major killer diseases in the world today, causing 
more deaths than all other diseases combined. The 
first WHO Global status report on NCDs 2010, 
confirms that 36.1 million people died from NCDs in 
2008. Nearly 80% of NCD deaths occur in low and 
middle income countries. NCDs are the most frequent 
cause of death in most countries except Africa. WHO 
predicts that NCDs will cause over three quarters of 
all deaths in 2030[1]. India is also passing through an 
epidemiological and demographic transition leading 
to the emergence of NCDs as major health problem, 
estimated to account for 53% of all deaths and & 44% 
of disability -adjusted life-years lost in 2005. 
 Traditional Ayurvedic approaches to health 
have become all the more relevant in the present 
century in the context of universal rise of NCDs. For 
these, Ayurveda has much to offer in terms of 
prevention, treatment, care and comfort. Ayurvedic 
approach to these conditions is holistic, which is a 
combination of diet, exercise, awareness of 
environmental influences and the use of medications. 
Ayurvedic science is targeting the long term well 
being of the diseased and not merely an instant relief. 
This aim is forgotten by the modern medicine, which 
gives only a temporary relief and long term side 
effects usually.  
 Dyslipidaemia is an extremely important 
condition, principally because of its contribution to 
atherogenesis and as it is an independent and 
modifiable risk factor for Cardio Vascular Disease 
(CVD), together with high BP, smoking and sedentary 
habits. The relation of Coronary Heart Disease and 
Hyperlipidaemia was a hypothesis until it was proved 
by the 4S study namely ‘The Scandanavian 
Simvastatin Survival Study’ which was done during 
1989-1994[2]. The ever increasing epidemic nature of 
the disease prompts the scientific researchers to 
understand the dimension of the condition. 
 It is here the greatness of Ayurvedic science 
resides, encoding all facts of life and disease, 
imbibing the practical implication of treatment based 
on the proper insight of the science. From Ayurvedic 
classics, an exact correlation of Dyslipidaemia to any 
disease cannot be made. Nomenclature and 
classification of diseases are not so important in 
Ayurveda[3]. Scientific treatment can be adopted by 
analyzing Dosha dooshya vikriti (imbalance of 
functional and structural entities of our body). [4] 
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 The indulgence of anomalous diet and 
activities leads to vitiation of Srotases (channels in 
the body). It is the root cause for all diseases. The 
abnormality in Dhatus (tissues) brings about 
abnormality in Srotases and vice-versa[5]. This leads 
to impairment of Agni (digestive fire) and formation 
of Ama (undigested food)[6]. This is followed by faulty 
Dhatuparinama (formation of tissues) and vitiated 
Medodhatu (fatty tisue) is formed[7].  
 Cirabilwa is a drug known from Samhita 
period, but detailed description is seen in Nighantus 
(different textbooks of Dravyagunavijnan). It 
possesses Tikta, Kasaya rasa (bitter and astringent 
taste), Laghu, Rooksha guna (easy to digest and is dry), 
Ushna veerya (hot potency) and Katu vipaka 
(transformation into pungent after digestion) [8]. It is 
included in many medohara ganas (groups of drugs 
having anti dyslipidaemic action) like Lekhana 
Mahakashaya group (group of drugs that dessicate 
and scrape away the morbid tissues especially meda 
and Kapha) of Caraka Samhita[9]; Shleshma 
Samsamana (groups of drugs which decrease kapha), 
several Kaphamedohara groups (groups of drugs 
which decrease Meda and Kapha) like Saalasaradi, 
Varanadi, Aragwadadi, Asanadi and Arkadi of Susruta 
Samhita[10]; Asanadi, Varanadi, Aragwadadi and 
Arkadi groups of Ashtanga Hridaya[11]. So an attempt 
was made to explain the Medohara action of 
Cirabilwa according to Ayurvedic as well as modern 
aspect.  
Methodology 
Literary review of Cirabilwa was taken from 
Ayurvedic classical texts viz. Samhita and Nighantus, 
different textbooks of Dravyagunavijnan for 
comprehensive information of the drug.  
OBSERVATIONS 
Etymology 
 The term Cirabilwa is derived from two root 
words Cira and Vila. Cira denotes a long duration 
/chronic. Vila denotes ‘Bhedana’ which means the act 
of dispelling [12]. Thus the word Cirabilwa means that 
which dispels chronic / long standing (diseases). 
Vernacular Names  
Sans.- Cirabilwa; Eng.- Indian Elm; Hindi- Chilbil; 
Marathi.- Papara; Punj.- Arjan; Guj.- Kanjho; 
Kannada- Tapasīgida, Tel.- Tapasi; Tam.- Avali; 
Mal.- Avil [13] 
Taxonomical Classification [14] 
Domain   : Eukaryota  
Kingdom  : Plantae  
Subkingdom :  Viridaeplantae  
Phylum  :  Tracheophyta  
Subphylum :  Euphyllophytina  
Infraphylum :  Radiatopses  
Class   :  Magnoliopsida  
Subclass  : Dilleniidae  
Super order :  Urticanae  
Order  :  Urticales  
Family  :  Ulmaceae  
Genus  :  Holoptelea  
Species  :  integrifolia  
Habitat and Morphology [15] 
It is a large spreading almost glabrous 
deciduous tree attaining a height of 15-18m, trunk 
upto 2 metres or more in girth near the ground level, 
covered with grey pustular mucilaginous bark 
(smooth and light coloured when young but 
becoming thick, greyish flaky and pustular in old 
trees), the branches quite greyish white and younger 
shoots tomentose. Leaves simple, alternate, 
distichous, elliptic or ovate, entire, glabrous, 
acuminate, penninerved with cordate or rounded 
base. Flowers are small, greenish, inconspicuous 
arranged in racemes or fascicles that arise from the 
axils of scars of fallen leaves of the previous years 
growth; fruits are flattened, thin, nearly orbicular, 
indehiscent samaroids, about 2.5 cms in diameter. 
The new leaves appear in March and April soon after 
the tree has flowered and the fruit which ripens 
during the hot season remains for a long time.  
Pharmacological uses [16] 
Anti inflammatory, digestive, carminative, 
laxative, anthelmintic, depurative, revulsive and 
urinary astringent. They are useful in vitiated 
conditions of Kapha and Pitta, inflammations, 
dyspepsia, flatulence, colic, helminthiasis, vomiting, 
skin diseases, leprosy, diabetes, haemorrhoids and 
rheumatism. 
Phytochemicals [17] 
Friedelin, friedalan -3-β-ol, epifriedelinol, 2-
Aminonaphthaquinone, β -sitosterol and its β -D-
glucoside isolated from stem bark. Hexacosanol, 
octacosanol, β –sitosterol and β –amyrin were 
isolated from leaves. 2- α, 3 -α-dihydroxyolean-12-
en-28-oic acid, β-sitosterol and hedaregenin were 
isolated from heart wood.  
Discussion 
 Dyslipidaemia is a term used to denote 
abnormal fractions of circulating lipids or 
lipoproteins in blood. It is an important health 
problem and a major risk factor for the development 
of Coronary Heart Diseases(CHD). Modern 
medications available for dyslipideamia are very 
costly and are potentially hazardous. So there is a 
need to find an effective, safe and cheap drug for this 
condition.  
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Dyslipidaemia as such is not mentioned in 
Ayurvedic classical texts. It can be considered as a 
particular condition of increased Medodhatu 
associated with increased Kapha dosha and deranged 
Kleda in the body.  
 One basic principle of Ayurveda is that similar 
factors cause increase and dissimilar factors cause 
decrease of our body constituents (Dosha, Dhatu and 
Mala). Based on this principle, Medohara effect of 
Cirabilwa can be explained. Medovikara is caused by 
the excessive indulgence of factors causing increase 
of Medodhatu, i.e., Foods having Madhura rasa (sweet 
taste), Seeta veerya (cold potency), Guru snigdha 
gunas (which is difficult to digest and is unctous) and 
sedentary life style. Thus treatment should be with 
drugs having Tikta katu kashaya rasa, Ushna veerya 
and Laghu rooksha guna. Cirabilwa is having Tikta 
Kashaya rasa, Laghu rooksha guna, Ushna veerya and 
Katu vipaka, thus possessing all the above properties.  
 Drugs having Katu rasa, Ushna veerya and 
Laghu guna can increase the strength of Agni which 
may act on improperly digested food. These 
properties can pacify Kapha, the main Dosha involved 
in Medovikara and dessicate vitiated Meda and Kleda, 
which are the contributing factors of Medovikara. 
Thus it can remove the obstruction of channels in our 
body. 
 Laghu rooksha guna and Katu rasa can act as 
Lekhana (dessicate and scrape away the morbid 
Dhatus and Malas especially Kapha and Meda) and 
chedana (drugs which forcefully detach the morbid 
Doshas). Cirabilwa is included in Lekhana 
Mahakashaya group of Caraka Samhita; Shleshma 
samsamana, several Kaphamedohara groups like 
Saalasaradi, Varanadi, Aragwadadi, Asanadi and 
Arkadi of Susruta Samhita; Asanadi, Varanadi, 
Aragwadadi and Arkadi groups of Ashtanga Hridaya . 
Drugs having these properties and Ushna veerya can 
also act as Pramathi (drugs that expel cumulative 
mala from channels). Hence the mode of action of 
Cirabilwa can be attributed principally to its Laghu 
rooksha guna, Ushna veerya, Tikta kashaya rasa and 
Katu vipaka, with which it exerts its Medohara karma 
by means of Lekhana, Chedana and Pramathi modes. 
 It is to be noted that β-sitosterol, a chemical 
constituent of Cirabilwa is used as a dietary 
supplement to lower blood cholesterol. β-Sitosterol 
inhibits cholesterol absorption in the intestine. When 
the sterol is absorbed in the intestine, it is 
transported by lipoproteins and incorporated into 
the cellular membrane. Phytosterols and 
phytostanols both inhibit the uptake of dietary and 
biliary cholesterol, decreasing the levels of LDL and 
serum total cholesterol. Because the structure of β-
sitosterol is very similar to that of cholesterol, β-
sitosterol takes the place of dietary and biliary 
cholesterol in micelles produced in the intestinal 
lumen. This causes less cholesterol absorption in the 
body. 
CONCLUSION 
 Non communicable diseases (NCDs) are the 
major killer diseases in the world today, causing 
more deaths than all other diseases combined. 
Traditional Ayurvedic approaches to health have 
become all the more relevant in the present century 
in the context of universal rise of NCDs. For these, 
Ayurveda has much to offer in terms of prevention, 
treatment, care and comfort. Dyslipidaemia is an 
extremely important condition, principally because of 
its contribution to atherogenesis and as it is an 
independent and modifiable risk factor for Cardio 
Vascular Disease (CVD), together with high BP, 
smoking and sedentary habits. Dyslipidaemia as such 
is not mentioned in Ayurvedic classical texts. It can 
be considered as a particular condition of increased 
Medodhatu associated with increased Kapha dosha 
and deranged Kleda in the body. Thus treatment 
should be with drugs having Tika katu kashaya rasa, 
Ushna veerya and Laghu rooksha guna. The study 
drug Cirabilwa is having Tika kashaya rasa, Laghu 
rooksha guna, Ushna veerya and Katu vipaka, thus 
possessing all the above properties. Moreover β-
sitosterol, a chemical constituent of Cirabilwa is used 
as a dietary supplement to lower blood cholesterol 
  
    Fig.1.1. Holoptelea integrifolia  Fig.1.2. Bark of H.integrifolia 
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     Fig.1.3. Leaves of H.integrifolia   Fig.1.4. Inflorescence of H. integrifolia  
  
 Fig.1.5. Fruits of H. integrifolia   Fig. 1.6. Stem bark of H. integrifolia  
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